MMP-9 expression is upregulated in glioma tissues, where it correlates with tumor grade [16], and its levels are significantly elevated in the serum of GB patients, suggesting its potential as a diagnostic marker for disease progression [19]. This evidence concerns the gene MMP9 and central nervous system cancer.